Hepion Pharmaceuticals, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
OQB
Hepion Pharmaceuticals is registering an additional $3 million in securities, including common stock and warrants, following a previous registration.
OQB
Hepion Pharmaceuticals plans to offer shares of common stock, pre-funded warrants, and common stock purchase warrants in a reasonable best efforts offering.
OQB
Hepion Pharmaceuticals is conducting a public offering of common stock and warrants to raise capital, primarily to repay outstanding debt and for general corporate purposes, following a terminated merger agreement and ongoing Nasdaq compliance issues.
OQB
Hepion Pharmaceuticals is registering for the resale of up to 1,470,590 shares of its common stock by a selling stockholder, potentially generating $2.8 million in gross proceeds for the company upon warrant exercises.